NOVAREX Co.,Ltd. (KOSDAQ:194700)
South Korea · Delayed Price · Currency is KRW 13,610
+210 (1.57%)
At close: Apr 9, 2026
NOVAREX Market Cap
NOVAREX has a market cap or net worth of 247.3 billion as of April 10, 2026. Its market cap has increased by 59.66% in one year.
Market Cap
247.30B
Enterprise Value
235.05B
Revenue
404.26B
Ranking
n/a
PE Ratio
6.98
Stock Price
13,610.00
Market Cap Chart
Since November 14, 2018, NOVAREX's market cap has increased from 180.98B to 247.30B, an increase of 36.65%. That is a compound annual growth rate of 4.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 9, 2026 | 240.93B | -2.79% |
| Dec 30, 2025 | 247.83B | 86.67% |
| Dec 30, 2024 | 132.77B | -38.22% |
| Dec 28, 2023 | 214.90B | 19.61% |
| Dec 29, 2022 | 179.68B | -41.23% |
| Dec 30, 2021 | 305.72B | -1.28% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Nov 14, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HEM Pharma | 453.97B |
| CellBion | 391.36B |
| DAE HWA Pharmaceutical | 244.18B |
| GREEN CROSS WellBeing | 234.24B |
| High Tech Pharm | 207.67B |
| OPTUS Pharmaceutical | 160.05B |
| Vivozon Pharmaceutical | 148.40B |
| Kyung Dong Pharmaceutical | 144.41B |